40,000 US patients suffer recurrent pericarditis; American Heart Association launches a 3-year initiative with Kiniksa Pharmaceuticals to improve diagnosis, treatment, and quality of life.

40,000 US patients suffer from recurrent pericarditis, an inflammation of the heart's protective sac causing chest pain. The American Heart Association launches a 3-year initiative backed by Kiniksa Pharmaceuticals. It aims to improve diagnosis, treatment, and quality of life for patients through sharing insights and best practices, addressing the issue of undiagnosed and untreated cases.